AviadoBio

Publications and Presentations

AVB-101 Six-month Preclinical Safety and Biodistribution Data Following Intrathalamic Delivery to Cynomolgus Monkeys Demonstrates Good Tolerability and Widespread Progranulin Expression in Brain Tissues

Date: Oct 25, 2023

Conference / Journal: ESGCT 2023

Author(s): Carlos J Miranda PhD

Intrathalamic Delivery of AVB-101 Rescues Pathology in Progranulin Deficient Mice and Achieves Widespread Cortical Expression in Two Large Animal Models

Date: Nov 4, 2022

Conference / Journal: ISFTD 2022

Author(s): Prof Chris Shaw

Intrathalamic Delivery of AVB-101 Rescues Pathology in Grn Null Mice and Achieves Widespread Cortical Expression in a Large Animal Model

Date: Oct 13, 2022

Conference / Journal: ESGCT 2022

Author(s): Youn Bok Lee, PhD

No results found.

ABOUT US

Learn more about our mission to transform lives and our industry-leading team

SCIENCE & Innovation

Find out more about our innovative gene therapies

 

Programs

Our pipeline and programs reflect our mission to deliver the future of gene therapy

 

 

CAREERS

When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission

 

CONTACT

We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here